AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05359770 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Active HD-tDCS
Description: Experimental group: 10-sessions of anodal HD-tDCS ( tDCS 1x1, developed by Soterix Medical Inc.) associated to respiratory training; for 20 minutes (each session). It will be delivered a 3mA intensity electrical current accordingly 10/20 International System on cortical representation zone of left diaphragmatic motor cortex using HD-tDCS.
Study NCT05359770 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Active HD-tDCS
Description: Experimental group: 10-sessions of anodal HD-tDCS ( tDCS 1x1, developed by Soterix Medical Inc.) associated to respiratory training; for 20 minutes (each session). It will be delivered a 3mA intensity electrical current accordingly 10/20 International System on cortical representation zone of left diaphragmatic motor cortex using HD-tDCS.
Study NCT05359770 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Control group
Description: Sham Control: 10-sessions of anodal HD-tDCS( tDCS 1x1, developed by Soterix Medical Inc.) associated to respiratory training; for 20 minutes (each session) with a 3mA intensity. The device will provide a 30-second ramp-up followed immediately by a 30-second ramp down.
Study NCT05359770 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Control group
Description: Sham Control: 10-sessions of anodal HD-tDCS( tDCS 1x1, developed by Soterix Medical Inc.) associated to respiratory training; for 20 minutes (each session) with a 3mA intensity. The device will provide a 30-second ramp-up followed immediately by a 30-second ramp down.
Study NCT04947995 — intervention group
Intervention type: DEVICE
Intervention: ctDNA multi-omics test
Description: The ctDNA multi-omics test for gastric cancer will be built based on low-pass WGS, methylation, and target region sequencing.
Study NCT05449938 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Scaling and root planing
Description: Scaling and root planing involves removal of plaque and calculus on tooth surface.
Study NCT05449938 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Scaling and root planing
Description: Scaling and root planing involves removal of plaque and calculus on tooth surface.
Study NCT00365001 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: tocilizumab [RoActemra/Actemra]
Description: 10mg/kg iv on day 8
Study NCT00365001 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: tocilizumab [RoActemra/Actemra]
Description: 10mg/kg iv on day 8
Study NCT00365001 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Methotrexate
Description: 10-25mg po/week
Study NCT00365001 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Methotrexate
Description: 10-25mg po/week
Study NCT00365001 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Simvastatin
Description: 40mg po on days 1, 15 and 43
Study NCT05848596 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: hand hygiene theoretical training
Description: Hand hygiene theoretical training~* Powerpoint presentation,~* How to ensure hand hygiene according to the demonstration method,
Study NCT05848596 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: hand hygiene theoretical + simulation training
Description: Hand hygiene theoretical training~* Powerpoint presentation,~* How to ensure hand hygiene according to the demonstration method,~Hand hygiene simulation training will be carried out by the researcher in an environment with a sink.~* Simulation-based training on standard patients,~* Hand hygiene application and important points to be considered during the application will be emphasized.
Study NCT04978805 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Progressive Relaxation Exercise
Description: In the progressive relaxation technique, the tension and anxiety in skeletal muscles are relatively relieved.
Study NCT06342583 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Advanced social relations training with technical device
Description: 15 participants from the experimental group will undergo a first part in which they will be guided through social stories to construct an appropriate conversation repertoire. In the first phase the participants will see 8 social stories with scenes from everyday life and after learning the correct mode of interaction and communication they will be asked to interact in the group by playing the roles previously seen in the social stories. These will be shown on a technological device. Participants will have the opportunity to choose the correct mode of interaction by selecting it directly on the technological device. Each selected alternative will refer to the next scenario in relation to the selected answers. In the second phase participants will be instructed on the correct use of social media. Slides will be shown to explain risks and correct use and the operator will show on the technological device (Smartphone) all the practical steps to be taken (e.g. privacy settings).
Study NCT06342583 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Advanced social relations training without technical device
Description: 15 participants from the control group will undergo a first part in which they will be guided through social stories to build an appropriate conversation repertoire. In the first phase, the participants will see eight social stories illustrating scenes from everyday life and, after learning the correct modes of interaction and communication, they will be invited to interact in the group by playing the roles previously seen in the social stories. These will be shown in traditional mode (flashcards). Participants will have the opportunity to choose the correct mode of interaction by touching the card showing the appropriate mode. Each selected alternative will refer to the next scenario in relation to the selected answers. In the second phase participants will be instructed on the correct use of social media (facebook, instagram, TikTok, Whatsapp, YouTube). The trainer will show images on paper related to risks and correct use of social media.
Study NCT05666921 — intervention group
Intervention type: OTHER
Intervention: psychological assessment
Description: The intervention consists in the assessment of some psychological aspects (emotional awareness, attachment style and the ability to abstract and symbolize (IQ)) of pediatric patients who present with somatic symptom disorders. , through specific tests. Each patient fills out the test battery during the psychological consult. At the same time, it is involved a parent to collect personal and clinical data through an ad hoc questionnaire.
Study NCT05602129 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HSK36273
Description: HSK36273
Study NCT05602129 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Heparin sodium
Description: Heparin sodium
Study NCT05220748 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: RM-1995
Description: RM-1995 will be administered by intravenous (IV) infusion followed approximately 24 hours later by tumor illumination with 690 nm non thermal red light using the PIT690 Laser System. The starting dose of RM-1995 will be 0.25 mg/kg and escalated up to 2.0 mg/kg over 6 dosing cohorts
Study NCT05220748 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: Pembrolizumab (200 mg) will be administered by intravenous (IV) infusion one week before the first RM-1995 PIT treatment and the second dose three weeks later for patients in the combination arm. Once the DLT window is complete, pembrolizumab dosage will be maintained at either 200 mg Q3w, or shift to 400 mg Q6w, per investigator discretion.
Study NCT05390463 — intervention group
Intervention type: OTHER
Intervention: PERformance guided Fracture Rehablitation Method (PERFoRM) protocol.
Description: A structured rehabilitation protocol for surgically treated peri-articular fractures of the upper extremity (proximal humerus and distal radius fractures).
Study NCT06385522 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: BITR2101
Description: TNFR2 monoclonal antibody
Study NCT06510387 — intervention group
Intervention type: DEVICE
Intervention: Ultrasound using suprasternal method
Description: The research resident will perform suprasternal ultrasound (US) with a curvilinear probe) C6-2) of US machine (Philips Affiniti 50) which will be placed transversely on the suprasternal area just above to the suprasternal notch immediately after intubation, The position of the trachea will be determined by a hyperechoic air-mucosa (A-M) interface with reverberation artifact posteriorly (comet-tail artifact).~The position of endotracheal tube (ETT), when it is placed in trachea, will be defined as observable contour between A-M and comet-tail artifact. If the second contour appears, it will be similar to the second airway which is called double-tract sign which means that the ETT will be in the esophagus. (7) If the position of the esophagus is suspected of being exactly behind the trachea, operator of ultrasound can specify the location of the esophagus by moving the probe to the left and right sides during scan.
Study NCT06510387 — intervention group
Intervention type: DEVICE
Intervention: Ultrasound using subxiphoid method
Description: Immediately after suprasternal sonography, the research resident will perform subxiphoid sonography to detect diaphragmatic motion, and information will be recorded.
Study NCT06061211 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: TREADMILL(SIDEA-Germany treadmill ) with TENS
Description: TENS:~MH8001 Portable tens 45 min. three times/ week 2-120 HZ 200ms~treadmill: SIDEA-Germany treadmill three times/week, 45min, moderate intensity according to claudication pain scale 2MPH(3.5KM/h) 0% grade then increase by 2% every 2min.
Study NCT06061211 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: TREADMILL(SIDEA-Germany treadmill ) with TENS
Description: TENS:~MH8001 Portable tens 45 min. three times/ week 2-120 HZ 200ms~treadmill: SIDEA-Germany treadmill three times/week, 45min, moderate intensity according to claudication pain scale 2MPH(3.5KM/h) 0% grade then increase by 2% every 2min.
Study NCT04327661 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tradipitant
Description: Oral Capsule
Study NCT04327661 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Oral Capsule
Study NCT05153668 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Everolimus Oral Tablet
Description: Everolimus 1.5mg by mouth daily will be given for 42 days after dilation surgery.
Study NCT05639010 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: regular hemodialysis
Description: Routine blood purification therapy (including hemodialysis, hemofiltration) 3 times a week
Study NCT05639010 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: regular hemodialysis
Description: Routine blood purification therapy (including hemodialysis, hemofiltration) 3 times a week
Study NCT05639010 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: hemoperfusion combined with hemodialysis
Description: Hemoperfusion combined with hemodialysis treatment will perform once a week. The hemoperfusion apparatus will use type KHA80 hemoperfusion apparatus (Zhuhai Jafron Biomedical Co., Ltd, China)
Study NCT04614103 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: LN-145
Description: A tumor sample is resected from each patient and cultured ex vivo to expand the population of tumor infiltrating lymphocytes. After lymphodepleting chemotherapy including cyclophosphamide and fludarabine, patient is infused with autologous TIL (LN-145), followed by IL-2.
Study NCT04614103 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: LN-145
Description: A tumor sample is obtained by image-guided core biopsy from each patient and cultured ex vivo to expand the population of tumor infiltrating lymphocytes. After lymphodepleting chemotherapy including cyclophosphamide and fludarabine, patient is infused with autologous TIL (LN-145) followed by IL-2.
Study NCT05837728 — intervention group
Intervention type: BEHAVIORAL
Intervention: Health promoting assessment of older adults living at home
Description: Based on the results of the first assessment of the older person's health determinants, healthcare professionals will recommend and tailor measures to the individual's needs to reduce the risk of functional decline and maintain their health while living at home.
Study NCT05065736 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 18F-Clofarabine
Description: The participants enrolled will receive a baseline CFA PET/CT evaluation. Then, the participants will undergo the routine follow up would normally occur for their cancer and its treatment. If this routine follow up and care involves repeat imaging of the cancer, then the CFA PET/CT scan will be repeated at that time (timed according to standard-of-care follow-up imaging), which is expected between a month to about 4 months after the first CFA PET/CT scan. The study period will end 24 hours after this repeat PET/CT scan.
Study NCT04895995 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Daylight dCBT Application
Description: Participants will complete up to four modules of digital intervention delivered in a self-paced format.
Study NCT05094544 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Non-ablative SBRT
Description: Non-ablative SBRT (800 cGy X 3 fractions) given 5-7 days preoperatively in selected patients with stage I-II NSCLC
Study NCT04717388 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: acoustics tests, Questionaries,
Description: acoustics tests at V1 Questionaries at V1~* cognitive~* emotional~* auditory
Study NCT04717388 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: MRI
Description: Anatomical and functional MRI at V2
Study NCT05956353 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Digital Storytelling Intervention
Description: Culturally tailored narrative-based videos created by individuals to promote colorectal, breast and cervical cancer screening among eligible participants in a primary care practice.
Study NCT05481918 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Home-based therapy after ACL reconstruction
Description: Five physiotherapeutic supervisions (individual) take place within the first 12-13 weeks after ACL reconstruction with focus on home exercises
Study NCT05481918 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Standardized ambulant therapy after ACL reconstruction
Description: 16 physiotherapeutic supervisions (groups+ individual) take place within the first 12-13 weeks after ACL reconstruction.
Study NCT06480578 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: ISS-SBDOH arm
Description: Once the ID-Cap ISS system has identified a participant who has missed his/her prescribed ARVs for five (5) consecutive days, a member of the multidisciplinary team will be informed automatically by the system and reach out to the participant immediately. The team will work with the primary provider and the participant to evaluate and understand the patient's SBDOH profile and status and develop a coordinated plan that fits the patient's specific need to address the patient's particular challenges in SBDOH. This plan (all SBDOH interventions) is considered standard of care and would be initiated in the same manner regardless of participation. Participation in this study will not alter the planned interventions determined by the HIV Care team.
Study NCT05530382 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: self-guided learning
Description: video-based self-directed learning for medical device training
Study NCT04932746 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Description: Infusion syringes are supplied with a concentration of 0.25 mcg / mL (dexmedetomidine or placebo) either 80 mcg / 20 mL, 200 mcg / 50 mL, or 400 mcg / 100 mL.~It begins with infusion of 4 ml within 10 minutes and then continues infusion, depending on the child's weight, at 1.6 ml / kg / h.~All injections will be prepared randomly by a doctor who did not participate in the study, and then placed in unmarked infusion pumps, given to an anesthesiologist (more than 10 years experience in pediatric anesthesia) without knowledge of the infusion content. The randomization process is carried out via sealed envelope technique.~The injections in both groups will be stopped before the skin is closed. Both patients and anesthesiologists blinded the study drug (dexmedetomidine or placebo) by infusion of solution (dexmedetomidine or placebo). Depending on the size in ml, to ensure that there is no bias and blindness to the medical team about what the drug is.
Study NCT04932746 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: The same anesthesia, the same amount of Saline solution will be administered, instead of dexmedetomidine, with the same protocol
Study NCT05566353 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Remote Check
Description: Remote Check is a remote monitoring tool which permits patients with Cochlear Nucleus CP1000 or CP1150 processors to complete hearing tests (pure-tone and speech-in-voice audiometry, electrode impedance measures, implant functioning assessment) at home,
Study NCT04257747 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: MRI acquisitions
Description: MRI acquisitions will be performed on the ACHIEVA 3T TX DStream Philips® Research MRI of the GIE Faire Faces.
Study NCT04257747 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: MRI acquisitions
Description: MRI acquisitions will be performed on the ACHIEVA 3T TX DStream Philips® Research MRI of the GIE Faire Faces.
Study NCT04257747 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: MRI acquisitions
Description: MRI acquisitions will be performed on the ACHIEVA 3T TX DStream Philips® Research MRI of the GIE Faire Faces.
Study NCT04257747 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Doppler ultrasound procedure
Description: The Doppler ultrasound procedure will be conducted in the traditional way in the Vascular Medicine Department of the Amiens-Picardie University Hospital
Study NCT04257747 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Doppler ultrasound procedure
Description: The Doppler ultrasound procedure will be conducted in the traditional way in the Vascular Medicine Department of the Amiens-Picardie University Hospital
Study NCT04257747 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Doppler ultrasound procedure
Description: The Doppler ultrasound procedure will be conducted in the traditional way in the Vascular Medicine Department of the Amiens-Picardie University Hospital
Study NCT05380388 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Malaria Vaccine
Description: blood stage Plasmodium vivax malaria vaccine
Study NCT05380388 — intervention group
Intervention type: BIOLOGICAL
Group type: OTHER
Intervention: HBV vaccine
Description: HBV Vaccine
Study NCT05851456 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Recombinant oncolytic herpes simplex virus type Ⅰ (R130)
Description: R130, a modified herpes simplex virus-Ⅰ (HSV-1) containing the gene coding for anti-CD3 scFv/CD86/PD1/HSV2-US11
Study NCT05054283 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Inflamatory biomarkers
Description: laboratuary parameters of within 24 hours of admission (levels of white blood cell (WBC), lymphocyte neutrophil, hemoglobin (Hb), platelet, fasting glucose, glycated hemoglobin, aspartate aminotransferase (AST) , c-reactive protein (CRP), ferritin, and procalcitonin) were recorded from medical records and collected by two trained fellow geriatricians.
Study NCT05549336 — intervention group
Intervention type: DRUG
Intervention: PD-1 inhibitor
Description: PD-1 inhibitor is defined as the exposure factor in our cohort study, for the tumor patients with the treatment of PD-1 inhibitor are allocated to the Exposure group whereas those tumor patients without the treatment of PD-1 inhibitor are allocated to the Non-exposure group.
Study NCT05579145 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: 5-Second Expiratory Pause
Description: Patients on mechanical ventilation for more than 24 hours will be randomized for the first technique to be applied. This technique consists of closed system aspiration and expiratory pause with mechanical ventilator for 5 seconds. After randomization and before the application of the technique, all patients will be positioned in supine position with the headboard elevated at 30 degrees and will be aspirated once with closed aspiration system and with vacuum of -40 cm H2O.
Study NCT05579145 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: 10-Second Expiratory Pause
Description: Patients on mechanical ventilation for more than 24 hours will be randomized for the first technique to be applied. This technique consists of closed system aspiration and expiratory pause with mechanical ventilator for 10 seconds. After randomization and before the application of the technique, all patients will be positioned in supine position with the headboard elevated at 30 degrees and will be aspirated once with closed aspiration system and with vacuum of -40 cm H2O.
Study NCT06151847 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biospecimen Collection
Description: A tumor sample is resected from each patient and cultured ex vivo to expand the population of tumor infiltrating lymphocytes. After lymphodepletion, patients are infused with Lifileucel followed by IL-2
Study NCT06151847 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Description: Given IV
Study NCT06151847 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Echocardiography
Description: Undergo echocardiography
Study NCT06151847 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fludarabine
Description: Given IV
Study NCT06151847 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Interleukin-2
Description: Given IV
Study NCT06151847 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Lifileucel
Description: Given IV
Study NCT06151847 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Magnetic Resonance Imaging
Description: Undergo MRI